Emergent BioSolutions
EBS
#6766
Rank
NZ$1.10 B
Marketcap
NZ$20.66
Share price
-1.24%
Change (1 day)
32.82%
Change (1 year)

Emergent BioSolutions (EBS) - Total assets

Total assets on the balance sheet as of September 2025 : NZ$2.53 Billion

According to Emergent BioSolutions 's latest financial reports the company's total assets are NZ$2.53 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Emergent BioSolutions - Total assets on balance sheet (from 2004 to 2025)

Total assets by year

Year Total assets Change
2024-12-31NZ$2.46 B-14.53%
2023-12-31NZ$2.88 B-42.19%
2022-12-31NZ$4.98 B15.17%
2021-12-31NZ$4.33 B8.37%
2020-12-31NZ$3.99 B15.63%
2019-12-31NZ$3.45 B3.97%
2018-12-31NZ$3.32 B120.56%
2017-12-31NZ$1.50 B7.6%
2016-12-31NZ$1.40 B-7.61%
2015-12-31NZ$1.51 B26.53%
2014-12-31NZ$1.19 B57.11%
2013-12-31NZ$0.76 B11.18%
2012-12-31NZ$0.68 B-2.11%
2011-12-31NZ$0.70 B8.05%
2010-12-31NZ$0.64 B36.65%
2009-12-31NZ$0.47 B-5.29%
2008-12-31NZ$0.50 B40.33%
2007-12-31NZ$0.35 B5.58%
2006-12-31NZ$0.33 B130.39%
2005-12-31NZ$0.14 B51.68%
2004-12-31NZ$96.77 M
2002-12-31NZ$43.54 M-28.87%
2001-12-31NZ$61.22 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Merck
MRK
NZ$224.91 B 8,766.94%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
NZ$0.40 B-84.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$143.16 B 5,544.11%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
NZ$1.12 B-55.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$362.39 B 14,186.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$69.19 B 2,627.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
NZ$19.6 M-99.23%๐Ÿ‡บ๐Ÿ‡ธ USA